Selective Serotonin Reuptake Inhibitors for the Prevention of Post-Stroke Depression: A Systematic Review and Meta-Analysis
There are controversial data on the efficacy and safety profile of selective serotonin reuptake inhibitors (SSRIs) to prevent post-stroke depression (PSD). We performed a systematic search in MEDLINE and SCOPUS databases to identify randomized-controlled trials questioning the use of early SSRI ther...
Main Authors: | Daniel Richter, Jeyanthan Charles James, Andreas Ebert, Aristeidis H. Katsanos, Lisa Mazul-Wach, Quirin Ruland, Ralf Gold, Georg Juckel, Christos Krogias |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/24/5912 |
Similar Items
-
New Serotonin-Norepinephrine Reuptake Inhibitors and Their Anesthetic and Analgesic Considerations
by: David Fanelli, et al.
Published: (2021-10-01) -
The effect of selective serotonin and norepinephrine reuptake inhibitors on clinical outcome of COVID‐19 patients: A systematic review and meta‐analysis
by: Dena Firouzabadi, et al.
Published: (2022-11-01) -
A case of severe paraneoplastic itch resistant to antihistamines and responding to serotonin reuptake inhibitors
by: Ines Werda, et al.
Published: (2021-07-01) -
Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review
by: Amber N. Edinoff, et al.
Published: (2021-08-01) -
Differentiated HT22 cells as a novel model for in vitro screening of serotonin reuptake inhibitors
by: Juhee Lim, et al.
Published: (2023-01-01)